AFYA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Afya Ltd is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown solid financial growth in the latest quarter, the technical indicators, analyst downgrades, and lack of strong trading signals suggest that the stock does not present an optimal entry point. Additionally, the absence of positive news or catalysts further supports a hold recommendation.
The technical indicators for AFYA suggest a neutral to bearish trend. The MACD is below zero and negatively contracting, RSI is neutral at 53.5, and the moving averages indicate a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 13.607, with resistance at 14.054 and support at 13.16.
The company's financial performance in Q3 2025 showed strong growth, with revenue up 10.38% YoY, net income up 29.33% YoY, EPS up 29.77% YoY, and gross margin improving by 3.12%.
Analysts have downgraded the stock multiple times recently, citing concerns over rising investments in non-core businesses, margin pressures, slower volume growth, and uncertainties in a volatile political year. Additionally, there is no recent positive news or significant trading activity from hedge funds, insiders, or Congress.
In Q3 2025, Afya reported revenue of 928.5M (up 10.38% YoY), net income of 155.2M (up 29.33% YoY), EPS of 1.7 (up 29.77% YoY), and a gross margin of 63.39% (up 3.12% YoY).
Analysts have downgraded Afya multiple times in recent months, with price targets reduced to a range of $16-$22. Concerns include slower growth in core operations, higher investments in non-core businesses, and margin pressures.
